Stock Research for DVAX

DVAX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

DVAX Stock Chart & Research Data

The DVAX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the DVAX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


DVAX Due diligence Resources & Stock Charts

The DVAX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View DVAX Detailed Price Forecast - CNN Money CNN View DVAX Detailed Summary - Google Finance
Yahoo View DVAX Detailed Summary - Yahoo! Finance Zacks View DVAX Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View DVAX Trends & Analysis - Trade-Ideas Barrons View DVAX Major Holders - Barrons
NASDAQ View DVAX Call Transcripts - NASDAQ Seeking View DVAX Breaking News & Analysis - Seeking Alpha
Spotlight View DVAX Annual Report - CompanySpotlight.com OTC Report View DVAX OTC Short Report - OTCShortReport.com
TradeKing View DVAX Fundamentals - TradeKing Charts View DVAX SEC Filings - Bar Chart
WSJ View Historical Prices for DVAX - The WSJ Morningstar View Performance/Total Return for DVAX - Morningstar
MarketWatch View the Analyst Estimates for DVAX - MarketWatch CNBC View the Earnings History for DVAX - CNBC
StockMarketWatch View the DVAX Earnings - StockMarketWatch MacroAxis View DVAX Buy or Sell Recommendations - MacroAxis
Bullish View the DVAX Bullish Patterns - American Bulls Short Pains View DVAX Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View DVAX Stock Mentions - StockTwits PennyStocks View DVAX Stock Mentions - PennyStockTweets
Twitter View DVAX Stock Mentions - Twitter Invest Hub View DVAX Investment Forum News - Investor Hub
Yahoo View DVAX Stock Mentions - Yahoo! Message Board Seeking Alpha View DVAX Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for DVAX - SECform4.com Insider Cow View Insider Transactions for DVAX - Insider Cow
CNBC View DVAX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for DVAX - OTC Markets
Yahoo View Insider Transactions for DVAX - Yahoo! Finance NASDAQ View Institutional Holdings for DVAX - NASDAQ


Stock Charts

FinViz View DVAX Stock Insight & Charts - FinViz.com StockCharts View DVAX Investment Charts - StockCharts.com
BarChart View DVAX Stock Overview & Charts - BarChart Trading View View DVAX User Generated Charts - Trading View


Latest Financial News for DVAX

Free Technical Research on Edge Therapeutics and Three More Biotech Equities
Posted on Monday July 09, 2018

On Friday, July 6, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. All sectors ended Friday's trading session in bullish territories. Taking into consideration last Friday's market sentiment, WallStEquities.com assessed the following Biotechnology equities this morning: CytomX Therapeutics Inc. (NASDAQ: CTMX), Dynavax Technologies Corp. (NASDAQ: DVAX), Edge Therapeutics Inc. (NASDAQ: EDGE), Editas Medicine Inc. (NASDAQ: EDIT).


Dynavax Appoints Scientific Advisory Board to Support its Oncology and Vaccine Programs
Posted on Thursday June 28, 2018

Dynavax Technologies Corporation (DVAX) today announced the formation of a six-member Scientific Advisory Board with significant experience in research, development, and commercialization in the fields of oncology and immunology.


Dynavax Presents Analysis of Data for Participants Aged 60 to 70 with Diabetes from its Phase 3 Trial of HEPLISAV-B®
Posted on Monday June 25, 2018

In a Post-Hoc Analysis of Elderly Diabetic Patients, HEPLISAV-B was Well-Tolerated and Induced Higher Rates of Seroprotection than Engerix-B. Data Presented at 2018 American Diabetes Association Annual ...


Dynavax to Present at the William Blair 38th Annual Growth Stock Conference
Posted on Monday June 11, 2018

BERKELEY, Calif., June 11, 2018-- Dynavax Technologies Corporation today announced that Michael Ostrach, Dynavax’ s Chief Financial Officer, will present at the William Blair 38th Annual Growth Stock Conference ...


Enter a stock symbol to view the stock details.